9. Medtronic
Implantable system for Remodulin
Medtronic’s implantable system for Remodulin is designed to treat patients who have pulmonary arterial hypertension. The system features the company’s SynchroMed II implantable drug infusion pump with a newly developed intravascular catheter that deliver Remodulin intravenously to patients who have previously received the drug through an external infusion pump.
Medtronic announced on July 31 that the system received FDA approval.